PHARM NL0010391025

Rapport

Real Time Euronext Amsterdam - 17:35:14 03-02-2023
1.252	EUR		+1.29%

01/02	AEX sluit met kleine winst	AM
30/01	Techaandelen onderuit in AEX	AM
27/01	Signify koploper in groene AEX	AM

Communiqués de presse de la société PHARMING GROUP N.V.

18/01	Pharming N : Bank of America Corporation - Pharming Group N.V. - Leiden	PU
17/01	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
12/01	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
2022	Pharming announces positive interim analysis data from open-label extension study of le..	AQ
2022	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
2022	Pharming announces positive interim analysis data from open-label extension study of le..	AQ
2022	Pharming announces publication of data from Phase 3 Study of leniolisib in patients wit..	AQ
2022	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
2022	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
2022	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
2022	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
2022	Pharming N : Q3 2022 Financial Results Presentation	PU
2022	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
2022	Pharming N : Halfjaarlijkse financiële verslaggeving	PU
2022	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
2022	Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden	PU
2022	Pharming N : Group reports financial results for the first half of 2022	PU
2022	Pharming N : H1 2022 Financial Results Presentation	PU
2022	Pharming N : Pharming Group presenteert tijdens de Jefferies Healthcare Conference	PU
2022	Pharming N : Group to present at Jefferies Healthcare Conference 2022	PU
2022	Pharming N : Aankondiging publicatie resultaten eerste kwartaal 2022	PU
2022	Pharming N : Group Notice of 2021 Full Year Results	PU
2021	B. Yanni - Pharming Group N.V. - Leiden	PU
2021	M. Pykett - Pharming Group N.V. - Leiden	PU
2021	D.A. Jorn - Pharming Group N.V. - Leiden	PU
2021	J. van der Meijs - Pharming Group N.V. - Leiden	PU
2021	S. Baert - Pharming Group N.V. - Leiden	PU
2021	P. Sekhri - Pharming Group N.V. - Leiden	PU
2021	L. Kruimer - Pharming Group N.V. - Leiden	PU
2021	Pharming Group reports financial results for the first nine months of 2021	PU
2021	Pharming N : Pharming Group Notice of 9M Results	PU
2021	Pharming N : Group Notice of 9M Results	PU
2021	Pharming N : Pharming announces results from clinical trials for the treatment of COVID-19..	PU
2021	Pharming N : announces results from clinical trials for the treatment of COVID-19 with RUC..	PU
2021	Pharming N : publiceert resultaten van klinische studies naar de behandeling van COVID-19 ..	PU
2021	Pharming N : Group reports financial results for the first half of 2021	PU
2021	Sign Up Now : Pharming's Half Year Financial Results Webinar	PU
2021	Pharming N : signs agreement with NewBridge Pharmaceuticals for the commercialization of R..	PU
2021	Pharming N : Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and..	PU
2021	Orchard Therapeutics : and Pharming Group Announce Collaboration to Develop and Commercial..	AQ
2021	Pharming N : Pharming announces completion of enrolment in Phase II/III study with lenioli..	PU
2021	Pharming N : announces completion of enrolment in Phase II/III study with leniolisib for a..	PU
2021	Pharming N : Pharming appoints Anurag Relan as Chief Medical Officer and Robert Friesen as..	PU
2021	Pharming N : benoemt Anurag Relan tot Chief Medical Officer en Robert Friesen tot Chief Sc..	PU
2021	Pharming N : appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Sc..	PU
2021	Pharming N : announces the reimbursement of RUCONEST® in Spain	PU
2021	Pharming N : Group to present at Jefferies Virtual Healthcare Conference	PU
2021	Pharming N : Group reports financial results for the first quarter of 2021	PU
2021	Pharming N : Group presenteert tijdens de 31ste jaarlijkse Oppenheimer Healthcare Conferen..	PU
2021	Pharming N : Group presenteert op BioCapital Europe 2021	PU
2021	Pharming N : Phishing, Pharming, Malware, And Other Internet Delights	AQ
2021	Pharming N : Group, in collaboration with Invitae Corporation, launches genetic testing pr..	PU
2021	Pharming N : Group start, in samenwerking met Invitae Corporation, genetisch testprogramma..	PU
2020	Pharming N : Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR..	PU
2020	Pharming N : Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq List..	PU
2020	Pharming N : Reports on Extraordinary General Meeting of Shareholders	PU
2020	Pharming N : announces enrolment of first patient in US clinical trial for the treatment o..	PU
2020	Pharming N : Juergen Ernst to retire from Pharming's Board of Supervisory Directors after ..	PU
2020	Pharming N : announces commitment to build a new downstream manufacturing facility for RUC..	PU
2020	Pharming N : appoints Jeroen Wakkerman as Chief Financial Officer	PU
2020	Pharming N : Group reports financial results for the first nine months of 2020	PU
2020	Pharming N : convenes Extraordinary General Meeting of shareholders	PU
2020	Pharming N : receives Orphan Drug Designation from the European Commission for leniolisib ..	PU
2020	Pharming N : announces the publication of data from a compassionate use programme of RUCON..	PU
2020	Pharming N : announces enrolment of first patient in multinational clinical trial for the ..	PU
2020	Pharming N : Group reports financial results for the first half of 2020	PU
2020	Pharming N : Seven Ways to Rob You during COVID-19	AQ
2020	Pharming N : reports encouraging results from use of RUCONEST® in COVID-19 patients	PU
2020	Pharming N : Group convenes Annual General Meeting of shareholders	PU
2020	Pharming N : Publication of Pharming's 2019 Annual Report	PU
2020	Pharming N : CFO to step down	PU
2020	Pharming N : Group Reports Strong Preliminary (Unaudited) Financial Results for 2019	PU
2020	Pharming N : receives EMA approval of new facility for expansion of RUCONEST® production	PU
2020	Pharming N : announces the placement of €125 million senior unsecured convertible bonds du..	PU
2020	Pharming N : announces the launch of an offering of approximately €125 million senior unse..	PU

1 2 3 Volgende

Analyse

AEX schudt volatiliteit af

Meer diepgaande analyses

Advies

PHARMING GROUP N.V.
A long journey

Meer tips

Volgende evenement op PHARMING GROUP N.V.

09/03/23

Boekjaar 2022 Cijferpublicaties (schatting)

De agenda van het bedrijf

Komende gebeurtenissen in de sector

18/04/23	JOHNSON & JOHNSON : Q1 2023 Cijferpublicaties
27/04/23	ELI LILLY AND COMPANY : Q1 2023 Cijferpublicaties
27/04/23	MERCK & CO., INC. : Q1 2023 Cijferpublicaties
04/05/23	NOVO NORDISK A/S : Q1 2023 Cijferpublicaties

Meer evenementen

Sector

Gezondheidszorg
	Farmaceutisch en medisch onderzoek
		Farmaceutische producten
			Farmaceutische producten
				Farmaceutische producten - Andere